Danyelle Ronke Okesanjo, APSW | |
1955 W Broadway, Monona, WI 53713-3700 | |
(608) 285-9101 | |
(608) 467-9635 |
Full Name | Danyelle Ronke Okesanjo |
---|---|
Gender | Female |
Speciality | Social Worker - Clinical |
Location | 1955 W Broadway, Monona, Wisconsin |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1063903680 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YM0800X | Counselor - Mental Health | 129731-121 (Wisconsin) | Secondary |
1041C0700X | Social Worker - Clinical | 129731-121 (Wisconsin) | Primary |
Mailing Address | Practice Location Address |
---|---|
Danyelle Ronke Okesanjo, APSW 1955 W Broadway, Monona, WI 53713-3700 Ph: (608) 285-9101 | Danyelle Ronke Okesanjo, APSW 1955 W Broadway, Monona, WI 53713-3700 Ph: (608) 285-9101 |
News Archive
Researchers at UCLA's Jonsson Comprehensive Cancer Center led by Dr. Karim Chamie have found that more intense surveillance and treatment of bladder cancer in the first two years after diagnosis could reduce the number of patients whose cancer returns after treatment and lower the disease's death rate. The study was published online ahead of press today in the journal Cancer.
Rice University bioengineers collaborated on a six-year study that systematically analyzed how the surface architecture of breast implants influences the development of adverse effects, including an unusual type of lymphoma.
The elderly are often prescribed multiple medications for different health conditions. While some medications are needed, polypharmacy and medication overload can be costly and even harmful. However, reducing the number of potentially inappropriate medications that seniors take on a daily basis is an ongoing challenge.
The proposed rule also would provide payment for care that helps patients make the transition back into the community following a discharge from a hospital or nursing facility.
"In parts of Africa, only about half of babies born to mothers with HIV receive the HIV prevention drug nevirapine," according to a study published Wednesday, HealthDay News/U.S. News & World Report reports.
› Verified 9 days ago